Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-transplant mycophenolate mofetil pharmacokinetic assessment in kidney transplantation
ACTRN12615000273583Phase 4Completed
- Sponsor
- Murdoch Children's Research Institute
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of mycophenolate mofetil in kidney allograft rejection (2 arms), sponsored by Murdoch Children's Research Institute. Primary endpoint: Proportion of patients within therapeutic MPA exposure range in the early post-transplant period. Started Jul 2015; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
kidney allograft rejection
Beyond the preview
Go deeper on ACTRN12615000273583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000273583.